11 reports

  • Antisense Therapeutics Ltd - Threats
  • Antisense Therapeutics Ltd - Strengths
  • Antisense
  • Biological Therapy
  • Netherlands
  • Company Financials
  • Antisense Therapeutics Limited
  • Antisense Therapeutics Ltd, Key Competitors
  • Antisense Therapeutics Ltd - Key Employees
  • Antisense
  • Biological Therapy
  • Therapy
  • Australia
  • Antisense Therapeutics Limited
  • SUMMARY ANALYSIS: Antisense Therapeutics Limited
  • Profitability Analysis: Antisense Therapeutics Limited
  • Antisense
  • Biological Therapy
  • Australia
  • Company Financials
  • Antisense Therapeutics Limited
  • Antisense Therapeutics Limited Overview
  • Antisense Therapeutics Limited Snapshot
  • Antisense
  • Europe
  • World
  • Product Initiative
  • Antisense Therapeutics Limited
  • JUL 24, 2012: ANTISENSE PHARMA RECEIVES FDA ORPHAN DRUG DESIGNATION FOR TRABEDERSEN TO TREAT MALIGNANT MELANOMA
  • MAR 01, 2016: ONCOTELIC PRESENTS TREATMENT WITH TRABEDERSEN- AN ANTI-TGF-BETA-2 ANTISENSE- PRIMED TUMORS TO SUBSEQUENT CHEMOTHERAPIES
  • Antisense
  • Brain Cancer
  • Ophthalmology
  • World
  • Isarna Therapeutics GmbH
  • ANTISENSE THERAPEUTICS LIMITED
  • JUN 17, 2016: ANTISENSE THERAPEUTICS PROVIDES UPDATE ON ATL1102 FOR MULTIPLE SCLEROSIS
  • Antisense
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • AB Science SA
  • JUN 04, 2012: ANTISENSE PHARMA PRESENTS TRABEDERSEN PHASE I/II COMPLETE DATA AT ASCO ANNUAL MEETING
  • MAR 01, 2016: ONCOTELIC PRESENTS TREATMENT WITH TRABEDERSEN- AN ANTI-TGF-BETA-2 ANTISENSE- PRIMED TUMORS TO SUBSEQUENT CHEMOTHERAPIES
  • Antisense
  • Brain Cancer
  • Ophthalmology
  • World
  • Isarna Therapeutics GmbH
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS - DRUG PROFILE
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS - DRUG PROFILE
  • Antisense
  • United States
  • World
  • Product Initiative
  • Galectin Therapeutics Inc.
  • ANTISENSE RNAI OLIGONUCLEOTIDES FOR LIVER DISEASES
  • ANTISENSE RNAI OLIGONUCLEOTIDE FOR LIVER FIBROSIS
  • Antisense
  • Oligonucleotide
  • Pharmaceutical
  • Research And Development
  • Dicerna Pharmaceuticals, Inc.
  • Ionis Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016
  • Ionis Pharmaceuticals, Inc. - Company Statement
  • Antisense
  • Pharmaceutical
  • Research And Development
  • United States
  • Ionis Pharmaceuticals, Inc.
  • Isis Pharmaceuticals, Inc. - Company Statement

It is an antisense oligonucleotide developed based on antisense technology.

  • Antisense
  • Pharmaceutical
  • Research And Development
  • United States
  • Isis Pharmaceuticals, Inc.